The global commercial market for cannabidiol (CBD)—a non-psychoactive phytocannabinoid isolated from the Cannabis sativa L. plant—represents one of the most volatile and complex regulatory battlegrounds in modern administrative law, international trade, and commercial jurisprudence. For decades, the extraction and commercialization of all cannabis-derived molecular compounds were bound by absolute prohibitionist statutory codes. However, the rapid […]